Abstract:Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Comment | <abbr>Open</abbr> | <a href="#article-info">Published: <time>05 April 2019</time></a>Cell Death & Diseasevolume 10, Article number: 306 (2019) | <a href="/articles/s41419-019-1542-0.ris"> Download Citation </a>Nitric oxide synthases are ubiquitous enzymes in malignant tumors, and known to exert both pro-tumor and anti-tumor effects. Endogenous NO is formed by three NOS isoforms (NOS1, NOS2 and NOS3) that differ in the way they modify transcription processes and enzyme activity<a href="/articles/s41419-019-1542-0#ref-CR1">1</a>. it is a ubiquitous messenger molecule capable of regulating multiple cellular signaling pathways<a href="/articles/s41419-019-1542-0#ref-CR2">2</a>,including those which modulate autophagy<a href="/articles/s41419-019-1542-0#ref-CR3">3</a>. Protein S-nitrosylation is a covalent post-translational modification that results from coupling a nitric oxide (NO) moiety containing a reactive thiol group to a protein cysteine residue to form an S-nitrosothiol (SNO) moiety<a href="/articles/s41419-019-1542-0#ref-CR4">4</a>. S-nitrosylation plays a key role in the transmission of NO-based cellular signals involved in vital cellular processes, including transcription regulation, DNA repair, apoptosis, and autophagy<a href="/articles/s41419-019-1542-0#ref-CR5">5</a>.Autophagy is a tightly-regulated catabolic process of cellular self-digestion by which cellular components are targeted to lysosomes for their degradation. Its functions are to provide energy and metabolic precursors under conditions of starvation and to alleviate stress by removal of damaged proteins and organelles, which is required for tumor cell survival during periods of starvation and ongoing tumorigenesis<a href="/articles/s41419-019-1542-0#ref-CR6">6</a>. However, excessive autophagy is commonly associated with cell death<a href="/articles/s41419-019-1542-0#ref-CR7">7</a>, and thus autophagy must be carefully regulated if cells are to survive under stressful conditions. Targeting the pro-death and pro-survival functions of autophagy has become a novel therapeutic strategy for treating cancer<a href="/articles/s41419-019-1542-0#ref-CR8">8</a>.Researches have reported that exogenous NO produced by the NO donor compound DETA-NONOate or the overexpression of three NOS family members creates a decrease in autophagic flux<a href="/articles/s41419-019-1542-0#ref-CR3">3</a>. Moreover, exogenous NO can induce S-nitrosylation of JNK1 and IKKB proteins, and thereby regulate autophagy via mTOR-dependent mechanisms (IKKB-AMPK-TSC2-mTORC1) and independent mechanisms (JNK-BCL-2-Beclin1)<a href="/articles/s41419-019-1542-0#ref-CR3">3</a>. As inhibiting the function of endogenous NOSs by L-NAME-enhanced autophagy does not require the two pathways mentioned above, endogenous NOSs might exert their effects on regulating autophagy by other mechanisms.It is well known that mTOR is a critical regulator of autophagy<a href="/articles/s41419-019-1542-0#ref-CR9">9</a>. However, the mTOR signaling pathway is regulated by numerous other upstream signaling pathways including PI3K/Akt. PTEN, a dual protein/lipid phosphatase, is a key regulator of the AKT/mTOR pathway. A mutation in the PTEN gene or a downregulation of PTEN protein production are frequent occurrences in several types of cancer, and lead to activation of the AKT/mTOR signaling pathway, which is associated with a poor clinical prognosis<a href="/articles/s41419-019-1542-0#ref-CR10">10</a>. PTEN in neuron cells was reported to become selectively S-nitrosylated at cysteine residue (Cys-83) in the presence of low concentrations of NO<a href="/articles/s41419-019-1542-0#ref-CR11">11</a>. Low concentrations of either exogenous or endogenous NO can selectively induce S-nitrosylation of PTEN at a specific cysteine residue (Cys-83)<a href="/articles/s41419-019-1542-0#ref-CR12">12</a>. Moreover, S-nitrosylation of PTEN leads to degradation of PTEN via a ubiquitin ligase NEDD4-1-mediated mechanism involving ubiquitin. This degradation is followed by hyper-activation of the Akt cascade in neuron cells<a href="/articles/s41419-019-1542-0#ref-CR13">13</a>. NOS1 is constitutively -Abstract Truncated-

PTPS Facilitates Compartmentalized LTBP1 S-Nitrosylation and Promotes Tumor Growth under Hypoxia.

PTP1B Controls Non-Mitochondrial Oxygen Consumption by Regulating RNF213 to Promote Tumour Survival During Hypoxia.

Original Protein tyrosine phosphatase PTPN2 regulates TGF- signaling through Smad4 dephosphorylation

PTPN3 Acts As a Tumor Suppressor and Boosts TGF-β Signaling Independent of Its Phosphatase Activity.

Abstract LB052: PTP1B inhibitors activate a novel hypoxia-induced inflammatory cell death pathway in breast cancer

PTEN S-nitrosylation by NOS1 inhibits autophagy in NPC cells

Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy

PTP1B Promotes Cell Proliferation and Metastasis Through Activating Src and ERK1/2 in Non-Small Cell Lung Cancer

Post-Transcriptional Regulation of Endothelial Nitric Oxide Synthase Expression by Polypyrimidine Tract–Binding Protein 1

Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer

PTEN Nuclear Localization is Regulated by Oxidative Stress and Mediates P53-Dependent Tumor Suppression

High-expressed PTPN1 Promotes Tumor Proliferation Signature in Human Hepatocellular Carcinoma

Ptpmt1 Induced by HIF-2α Regulates the Proliferation and Glucose Metabolism in Erythroleukemia Cells.

TCTP Increases Stability of Hypoxia‐inducible Factor 1α by Interaction with and Degradation of the Tumour Suppressor VHL

Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments

TCTP protein degradation by targeting mTORC1 and signaling through S6K, Akt, and Plk1 sensitizes lung cancer cells to DNA-damaging drugs

PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension

Inhibition of PTP1B Blocks Pancreatic Cancer Progression by Targeting the PKM2/AMPK/mTOC1 Pathway

PTPN14 Promotes Gastric Cancer Progression by PI3KA/AKT/mTOR Pathway

Unravelling biological processess and EGFR pathway regulation by the receptor-like protein tyrosine phosphatase PTPRH in non-small cell lung cancer

A mechanism for hypoxia-induced inflammatory cell death in cancer